B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS Pathogens 7.8 (2011)
- Keyword
-
-
Infektion
Infektiologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2012
- Contributor
-
Pötzsch, Sonja
Spindler, Nadja
Wiegers, Anna-Katharina
Fisch, Tanja
Rücker, Pia
Sticht, Heinrich
Grieb, Nina
Baroti, Tina
Weisel, Florian
Stamminger, Thomas
Martin-Parras, Luis
Mach, Michael
Winkler, Thomas H.
- URN
-
urn:nbn:de:bvb:29-opus-31650
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pötzsch, Sonja
- Spindler, Nadja
- Wiegers, Anna-Katharina
- Fisch, Tanja
- Rücker, Pia
- Sticht, Heinrich
- Grieb, Nina
- Baroti, Tina
- Weisel, Florian
- Stamminger, Thomas
- Martin-Parras, Luis
- Mach, Michael
- Winkler, Thomas H.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2012
Other Objects (12)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
A comprehensive antibody repertoire analysis reveals novel antigenic domains on glycoprotein B of human cytomegalovirus that induce potently neutralizing antibodies : = Neue antigene Domänen für die Induktion von neutralisierenden Antikörpern auf Glykoprotein B des humanen Cytomegalovirus
Neutralizing antibodies as tools for structure-based vaccine design